Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

167 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Controversies Surrounding Renal Denervation: Lessons Learned From Real-World Experience in Two United Kingdom Centers.
Burchell AE, Chan K, Ratcliffe LE, Hart EC, Saxena M, Collier DJ, Jain AK, Mathur A, Knight CJ, Caulfield MJ, Paton JF, Nightingale AK, Lobo MD, Baumbach A. Burchell AE, et al. Among authors: knight cj. J Clin Hypertens (Greenwich). 2016 Jun;18(6):585-92. doi: 10.1111/jch.12789. Epub 2016 Feb 9. J Clin Hypertens (Greenwich). 2016. PMID: 26857092 Free PMC article. Review.
Joint UK societies' 2014 consensus statement on renal denervation for resistant hypertension.
Lobo MD, de Belder MA, Cleveland T, Collier D, Dasgupta I, Deanfield J, Kapil V, Knight C, Matson M, Moss J, Paton JF, Poulter N, Simpson I, Williams B, Caulfield MJ; British Hypertension Society; British Cardiovascular Society; British Cardiovascular Intervention Society; Renal Association. Lobo MD, et al. Heart. 2015 Jan;101(1):10-6. doi: 10.1136/heartjnl-2014-307029. Epub 2014 Nov 27. Heart. 2015. PMID: 25431461 Free PMC article.
Central arteriovenous anastomosis for the treatment of patients with uncontrolled hypertension (the ROX CONTROL HTN study): a randomised controlled trial.
Lobo MD, Sobotka PA, Stanton A, Cockcroft JR, Sulke N, Dolan E, van der Giet M, Hoyer J, Furniss SS, Foran JP, Witkowski A, Januszewicz A, Schoors D, Tsioufis K, Rensing BJ, Scott B, Ng GA, Ott C, Schmieder RE; ROX CONTROL HTN Investigators. Lobo MD, et al. Lancet. 2015 Apr 25;385(9978):1634-41. doi: 10.1016/S0140-6736(14)62053-5. Epub 2015 Jan 23. Lancet. 2015. PMID: 25620016 Clinical Trial.
Atypical risk factor profile and excellent long-term outcomes of young patients treated with primary percutaneous coronary intervention for ST-elevation myocardial infarction.
Rathod KS, Jones DA, Gallagher S, Rathod VS, Weerackody R, Jain AK, Mathur A, Mohiddin SA, Archbold RA, Wragg A, Knight CJ. Rathod KS, et al. Among authors: knight cj. Eur Heart J Acute Cardiovasc Care. 2016 Feb;5(1):23-32. doi: 10.1177/2048872614567453. Epub 2015 Jan 14. Eur Heart J Acute Cardiovasc Care. 2016. PMID: 25589633
Risk scoring to guide antiplatelet therapy post-percutaneous coronary intervention for acute coronary syndrome results in improved clinical outcomes.
Antoniou S, Colicchia M, Guttmann OP, Rathod KS, Wright P, Fhadil S, Knight CJ, Jain AK, Smith EJ, Mathur A, Weerackody R, Wragg A, Jones DA. Antoniou S, et al. Among authors: knight cj. Eur Heart J Qual Care Clin Outcomes. 2018 Oct 1;4(4):283-289. doi: 10.1093/ehjqcco/qcx041. Eur Heart J Qual Care Clin Outcomes. 2018. PMID: 29126112
167 results